Quarterly report pursuant to Section 13 or 15(d)

Accrued expenses and other current liabilities (Details)

v3.24.2.u1
Accrued expenses and other current liabilities (Details) - USD ($)
$ in Thousands
Jun. 30, 2024
Dec. 31, 2023
Accrued expenses and other current liabilities    
Accrued clinical and development expenditure $ 16,046 $ 12,351
Accrued employee expenses 9,637 13,226
VAT Payable   1,398
Other accrued expenditure 5,060 3,277
Other 107 51
Total $ 30,850 $ 30,303